Schaper Benz & Wise Investment Counsel’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,336
Closed -$237K 161
2026
Q1
$237K Buy
3,336
+400
+14% +$31.5K 0.02% 151
2025
Q4
$241K Buy
2,936
+105
+4% +$8.18K 0.02% 149
2025
Q3
$213K Sell
2,831
-41
-1% -$3.06K 0.02% 150
2025
Q2
$213K Hold
2,872
0.02% 147
2025
Q1
$232K Sell
2,872
-24
-0.8% -$2.06K 0.02% 144
2024
Q4
$226K Sell
2,896
-601
-17% -$51.1K 0.02% 145
2024
Q3
$328K Buy
3,497
+248
+8% +$20.8K 0.03% 131
2024
Q2
$253K Sell
3,249
-914
-22% -$74.6K 0.02% 133
2024
Q1
$378K Sell
4,163
-4,130
-50% -$344K 0.03% 121
2023
Q4
$641K Sell
8,293
-194
-2% -$13.6K 0.06% 99
2023
Q3
$577K Sell
8,487
-287
-3% -$20.9K 0.06% 102
2023
Q2
$713K Sell
8,774
-1,656
-16% -$132K 0.07% 100
2023
Q1
$856K Buy
+10,430
New +$745K 0.09% 95

Other funds holding GEHC

Schaper Benz & Wise Investment Counsel's GEHC Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 3,336 shares — an estimated $237K sold.

Schaper Benz & Wise Investment Counsel first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $856K in Q1 2023. 443 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Schaper Benz & Wise Investment Counsel sold 3,336 GE HealthCare shares in Q2 2026, an estimated $237K.
  • Schaper Benz & Wise Investment Counsel first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Schaper Benz & Wise Investment Counsel's GE HealthCare position peaked at $856K in Q1 2023.
  • 443 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.